RIPK1 and neoplasm: In addition, fragile X mental retardation protein (FMRP) binds to RIPK1 mRNA, and treatment with FMR1 anti-transcription upregulates RIPK1, leading to the necroptosis of CRC cells and the inhibition of tumor growth [113].